Use of Nanorobots in Neuro chemotherapy diagnosis in human

This scholarly work presents a research and exploration on the employment of nanorobots in diagnosis of neurochemotherapy, a multifield condition involving nanotechnology, neurology, and oncology.The Nanorobots include self-operated machines having size of 1-100 nanometres, thus can play a significant role in early detection of Brain Tumours and also in tracking down cellular level response to the treatment.Nanorobots employed in this domain often include DNA origami structures, magnetic nanoparticles, and carbon nanotubes, each offering unique capabilities such as targeted delivery, real-time tracking, and enhanced imaging contrast.In line with the current writing and available clinical trials, this paper undertakes an analysis of features that show that indeed, nanorobots can diagnose diseases with accuracy of over 95 percent, this include having a low chance of false positives, which can be up to 60 percent lower than the chances of conventional imaging.All these developments keep the public a hope that breakthrough in the field of diagnosis or treatment of brain tumours may possibly enhance prognosis, a niche that depends heavily on early diagnosis.However, there are great opportunities in miniaturization, repeatability for manufacturing at scale, and creating durable solutions for biocompatibility issues that scientists and engineers will have to face in the future as well as there are great potentials in moving from the lab into the clinic.Other challenges relate to ethical issues such as patients' privacy and social justice in terms of accessibility of the superior diagnostics.In general, nanorobots are regarded as one of the most promising tools in the diagnosis and treatment of neurochemotherapy in the future decades with regard to brain tumours.